New program aims to curb overuse of antibiotics in children

NCT ID NCT05127161

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a program to help doctors prescribe antibiotics more appropriately for common childhood infections like earaches, sore throats, and sinusitis. Over 1,000 doctors took part, receiving online training, personalized feedback on their prescribing habits, and support from champions. The goal was to reduce unnecessary broad-spectrum antibiotic use and fight antibiotic resistance.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
behavioral intervention (online training, feedback reports, and support)
What this could lead to
If successful, this approach could help reduce unnecessary antibiotic use in children, slowing antibiotic resistance and preventing side effects.
What could go wrong
This is an implementation study, not a drug trial. Results depend on how well doctors follow the program, and benefits may vary across different clinics.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY TRACT INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania, 19104, United States

  • MetroHealth

    Cleveland, Ohio, 44109, United States

  • Nationwide Children's Hospital

    Cleveland, Ohio, 43205, United States

  • Pediatric Associates

    Plantation, Florida, 33324, United States

  • Penn State Health

    Hershey, Pennsylvania, 17033, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.